Cyclophosphamide Pulse Therapy Normalizes Vascular Abnormalities in a Mouse Model of Systemic Sclerosis Vasculopathy-Reference-Cited by-同舟云学术

Cyclophosphamide Pulse Therapy Normalizes Vascular Abnormalities in a Mouse Model of Systemic Sclerosis Vasculopathy

Published:2019-05 Issue:5 Volume:139 Page:1150-1160
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Yamashita Takashi,Asano Yoshihide,Saigusa Ryosuke,Taniguchi Takashi,Hirabayashi Megumi,Miyagawa Takuya,Nakamura Kouki,Miura Shunsuke,Yoshizaki Ayumi,Trojanowska Maria,Sato Shinichi

Funder

National Institutes of Health

Shimabara Science Promotion Foundation

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference49 articles.

1. Endothelin receptor blockade ameliorates vascular fragility in endothelial cell-specific Fli-1-knockout mice by increasing Fli-1 DNA binding ability;Akamata;Arthritis Rheumatol,2015

2. Effects of dazmegrel, piroxicam and cyclophosphamide on the NZB/W model of SLE;Archer;Agents Actions,1989

3. Vasculopathy in scleroderma;Asano;Semin Immunopathol,2015

4. Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy;Asano;Am J Pathol,2010

5. Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering;Beamish;Tissue Eng Part B Rev,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FLI-1-driven regulation of endothelial cells in human diseases;Journal of Translational Medicine;2024-08-06

2. Further insight into systemic sclerosis from the vasculopathy perspective;Biomedicine & Pharmacotherapy;2023-10

3. Fli1 and Tissue Fibrosis in Various Diseases;International Journal of Molecular Sciences;2023-01-18

4. Serum vasohibin‐1 levels: A potential marker of dermal and pulmonary fibrosis in systemic sclerosis;Experimental Dermatology;2021-03-16